Premium
Histrelin acetate: gonadorelin analogue given once a year
Author(s) -
Chaplin Steve,
Persad Raj
Publication year - 2010
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.586
Subject(s) - medicine , prostate cancer , adverse effect , implant , gynecology , cancer , surgery
Histrelin acetate (Vantas) is a gonadorelin analogue implant for the palliative treatment of advanced prostate cancer given once a year. In our New products review, Steve Chaplin presents the clinical data relating to its efficacy and adverse effects, and Mr Raj Persad considers its potential place in treatment. Copyright © 2010 Wiley Interface Ltd.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom